Phuturdex › Diseases › Accidental Injuries
Drugs in development · updated 13 November 2026
Accidental Injuries: drugs in development
What it is
Injuries resulting from events or circumstances that are unforeseen, unplanned, unanticipated, and without premeditation.
Source: NLM MeSH (U.S. National Library of Medicine), descriptor D000081084, meshb.nlm.nih.gov · public domain · downloaded on 13 November 2026.
As of 13 November 2026 there are 4 active clinical trials (recruiting or ongoing, phases I–III) on 3 drugs for accidental Injuries. None is experimental: all are already approved in the United States, for this or other indications.
In Phuturdex every drug has its map of sites in Europe, every trial and its alerts, and you get an email when something changes. Full access free until 31 March 2027, no card needed.
Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| Tranexamic AcidTransexamic acid, Lysteda® | III | 2 | NCT06070350 |
| Thrombate | II | 1 | NCT05794165 |
| DexamethasoneDexametasone, Dexamethesone | Early I | 1 | NCT07343817 |
Sorted by most advanced phase and number of active trials.
All 3 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Broader categories
- Wounds and Injuries 191 drugs
- Nervous System Diseases 1,473 drugs
- Vascular disease 832 drugs
- Cardiovascular disease 987 drugs
- Hemorrhage 139 drugs
- Brain Diseases 855 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 13 November 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: NLM MeSH; NLM MeSH term: D000081084 “Accidental Injuries”.